1-((2-BROMO-6-QUINOXALINYL)METHYL)-4-(4-(1-METHYLETHYL)PHENYL)-6-(2-PROPYN-1-YLOXY)-2(1H)-QUINAZOLINONE
UNII 8VK61D7U5D
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((2-bromo-6-quinoxalinyl)methyl)-4-(4-(1-methylethyl)phenyl)-6-(2-propyn-1-yloxy)-2(1h)-quinazolinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8VK61D7U5D.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2772860-39-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H23BrN4O2 ALANRBCCCQEPFZ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((2-bromo-6-quinoxalinyl)methyl)-4-(4-(1-methylethyl)phenyl)-6-(2-propyn-1-yloxy)-2(1h)-quinazolinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.